Disease Info Card

Endometrial Stromal Sarcoma

Information about Endometrial Stromal Sarcoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Endometrial Stromal Sarcoma

Most recent studies have shown that Endometrial Stromal Sarcoma shares some biological mechanisms with adenocarcinoma, carcinoma, carcinosarcoma, endometrial-carcinoma, endometrial-neoplasms, endometrial-polyp, endometrial-stromal-tumors, endometriosis-site-unspecified, hemorrhage, leiomyosarcoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, sarcoma, uterine-corpus-sarcoma, uterine-fibroids, uterine-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Endometrial Stromal Sarcoma, and have been seen in publications frequently: Cell Cycle, Cell Differentiation, Cell Growth, Cell Proliferation, Cytokine Production, Dedifferentiation, Interphase, Invasive Growth, Localization, Menopause, Menstruation, Methylation, Mismatch Repair, Mitosis, Oncogenesis, Ovulation, Pathogenesis, Reverse Transcription, Secretion

Quite a number of genes have been found to play important roles in Endometrial Stromal Sarcoma, such as CD34, CDKN1A, CYP19A1, DES, ESR1, JAZF1, KIT, MID1, MME, PGR, SLC4A1, SUB1, SUZ12, TMEM37, TP53, TP63, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.